This section addresses the application and permitting
requirements of persons regulated under part I of chapter 499, F.S.
(1) Any person that is required under
sections 499.001-.081, F.S., to have a permit shall apply to the department for
the appropriate permit on forms indicated in this rule. Inquiries regarding
requests for an application or licensing may be directed to The Department of
Business and Professional Regulation, Drugs, Devices, and Cosmetics Program,
2601 Blair Stone Road, Tallahassee, Florida 32399-1047 or telephone number
(850)717-1800. Applications may be downloaded from the bureau's web site at
www.myfloridalicense.com.
(2) A permit is valid only for the name and
address to which it is issued. The name in which a permit is issued will be
changed, at no cost, upon notification to the department.
(a) The name in which the permit is issued
must be the name in which the company is doing business, i.e., the name that
appears on purchase and sales invoices.
(b) A permit that authorizes the purchase of
prescription drugs will not be issued in a name identical to the name used by
any other establishment or licensed permit holder at that address authorized to
purchase prescription drugs pursuant to chapter 465, F.S., or the statutes
regulating a practitioner authorized to purchase prescription drugs except:
1. A Restricted Rx Drug Distributor -
Charitable Organization permit will be issued in the name of the charitable
organization or health care entity, and
2. A Medical Oxygen Retailer permit may be
issued in the name of a nursing home's Class I Institutional Pharmacy
permit.
(c) A person must
be available for inspection at the permitted address during the business hours
identified on the application form, holidays excluded. Permanent changes to
these business hours must be communicated to the department in writing. At a
minimum, these business hours must meet the following standards:
1. For an establishment applying for a permit
or permitted as a prescription drug wholesaler or prescription drug wholesaler
- broker only, the establishment must designate a minimum of 20 hours weekly
between the hours of 8:00 a.m. and 5:00 p.m. (EST), Monday through Friday, and
at least one day of the week provide for four consecutive hours.
2. For an establishment applying for a permit
or permitted only as a medical oxygen retailer and which does not transfill
medical oxygen containers at the permitted establishment, the establishment
must designate a minimum of four (4) hours weekly between the hours of 8:00
a.m. and 5:00 p.m. (EST), Monday through Friday, and at least one day of the
week provide for two consecutive hours. Furthermore if less than 10 hours
weekly are designated, a medical oxygen retailer must be available by telephone
between the hours of 8:00 a.m. to 5:00 p.m., Monday through Friday, to schedule
an appointment within 24 hours of the department's telephone call for an
inspection during non-designated business hours.
3. Other applicants and permitted
establishments must designate a minimum of 10 hours weekly between the hours of
8:00 a.m. and 5:00 p.m. (EST), Monday through Friday, and at least one day of
the week provide for two consecutive hours. These standards set forth minimum
business hours and agents of the Department of Business and Professional
Regulation and the Department of Law Enforcement may inspect, monitor, and
investigate during other hours as authorized by
law.
(3)
On-site Inspections. Passing an on-site inspection is a prerequisite to
issuance of a new permit for the following permit types: Prescription Drug
Manufacturer, Device Manufacturer, Compressed Medical Gases Manufacturer,
Over-the-Counter Drug Manufacturer, Cosmetic Manufacturer, Prescription Drug
Wholesaler, Compressed Medical Gases Wholesaler, Freight Forwarder, Veterinary
Prescription Drug Wholesaler located in Florida, Veterinary Legend Drug
Retailer, Medical Oxygen Retailer, and Restricted Rx Drug Distributor permits
for the Health Care Entity, Reverse Distributor, and Destruction facilities.
However, the department may elect to perform an inspection of the Restricted Rx
Drug Distributor - Charitable Organization, Government Program, or
Institutional Research as a condition of permitting but an on-site inspection
fee will not be assessed.
(a)
1. A person permitted as a Prescription Drug
Manufacturer that is applying for additional manufacturing permits, a
Complimentary Drug Distributor permit, or a Prescription Drug Wholesaler permit
at that address does not require another on-site inspection and is not required
to pay an initial application/on-site inspection fee when applying for the
additional permits.
2. A person
permitted as an Over-the-Counter Drug Manufacturer that is applying for a
Device Manufacturer permit or Cosmetic Manufacturer permit at that address does
not require another on-site inspection and is not required to pay an initial
application/on-site inspection fee when applying for the additional
permit.
3. A person permitted as a
Cosmetic Manufacturer or Device Manufacturer that is applying for a Device
Manufacturing permit or Cosmetic Manufacturing permit does not require another
on-site inspection and is not required to pay an initial application/on-site
inspection fee when applying for the additional permit.
(b) A person permitted as a Compressed
Medical Gases Manufacturer that is applying for either a Compressed Medical
Gases Wholesaler permit or a Medical Oxygen Retailer permit at that address
does not require another on-site inspection and is not required to pay an
initial application/on-site inspection fee when applying for the additional
permit.
(c) A person permitted as a
Medical Oxygen Retailer that is applying for a Compressed Medical Gases
Wholesaler permit at that address does not require another on-site inspection
and is not required to pay the initial application/on-site inspection fee when
applying for the additional permit. A person permitted as a Medical Oxygen
Retailer that has the establishment registered with the FDA for transfilling
activity which is applying for a Compressed Medical Gases Manufacturer's permit
at that address does not require another on-site inspection and is not required
to pay the initial application/on-site inspection fee when applying for the
additional permit.
(d) The
department will request from the applicant written documentation to evidence
compliance with the requirements of chapter 499, F.S., when an on-site
inspection cannot be completed within 30 days of receipt of a completed
application for a permit requiring an on-site inspection or a written request
for a change of address.
(4) Written policies and procedures as
required by chapter 499, F.S., and this rule chapter must be established prior
to approval of a permit application. A prescription drug wholesaler that uses a
system to digitally sign and electronically authenticate an electronic pedigree
must have policies and procedures to protect the security over the digital
signatures.
(5) Notification to the
department regarding the change of address of a permitted establishment must be
in writing. A Change of Address form is available on the department's web site.
Notification regarding the closing of a permitted establishment shall also
include the name and address of a person to contact for up to two years after
the closing of the business for access to required records.
(6) Manufacturer Permits.
(a) A prescription drug manufacturer's
permit, over-the-counter drug manufacturer's permit, or device manufacturer's
permit is not required for the manufacture of products that are in an FDA
approved investigational program and that are not manufactured for clinical
investigation (for actual use in or on humans or animals).
(b) A device manufacturer's permit is
required for an establishment that refurbishes medical devices for subsequent
sale but is not required when the refurbishing is performed as a service for
the owner of the medical device and the device is returned to the owner for
further use.
(c) Application
requirements for manufacturers and precription drug repackagers located in
Florida include:
1. Contact the department's
Drugs, Devices, and Cosmetics Program to request an application or download the
application from the department's website.
2. File with the department a completed
application for a permit using an original Form DH 1033, "Application for
Permit Under chapter 499, F.S., " effective August 2004, which is incorporated
by reference herein.
3. Pay the
appropriate fee(s) as required by rule
61N-1.018, F.A.C.
4. Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule chapter.
5. Have an FDA establishment registration
number, or unless the application is for a cosmetic manufacturer, provide
documentation to the department supporting an exemption from FDA
registration.
(d)
Application requirements for Non-resident prescription drug (Rx) manufacturers.
1. A person may qualify as a Non-resident Rx
drug manufacturer if
a. The establishment is
not located in Florida; and
b.
(I) The person and establishment physically
manufacture a prescription drug either for itself or as a contract
manufacturer; or
(II) The person is
the holder of an approved New Drug Application (NDA), Abbreviated New Drug
Application (ANDA), or New Animal Drug Application (NADA); or
(III) The person and establishment is a
private label distributor and the private label distributor's prescription
drugs are originally manufactured and labeled for the distributor and have not
been repackaged; or
(IV) The
establishment is the distribution point for the manufacturer, contract
manufacturer or private label distributor whether the establishment is a member
of the manufacturer's affiliated group or is a contract distribution site;
or
(V) The person and establishment
import prescription drugs, including active pharmaceutical ingredients also
referred to as bulk ingredients that are lawful in interstate
commerce.
2. A
non-resident Rx drug manufacturer that also distributes prescription drugs that
it did not manufacture (as meeting one of the criteria above) will also need to
apply for an out-of-state prescription drug wholesaler permit and meet all of
the requirements for obtaining that permit.
3. Contact the department's Drugs, Devices,
and Cosmetics Program to request an application or download the application
from the department's website.
4.
File with the department a completed application for a permit using an original
Form DH 1033, "Application for Permit Under chapter 499, F.S., " effective
August 2004.
5. Submit a photocopy
of all permits or licenses issued to the applicant's address which authorize
the manufacture or possession of prescription drugs at that address, regardless
of the issuing agency. If the issuing agency prohibits photocopying the permit
or license, the applicant may submit a state verification of any permits or
licenses issued to the applicant's address.
6. If the non-resident Rx drug manufacturer
is importing prescription drugs, FDA approval can be documented with:
a. An NDA number for the product;
or
b. Evidence of an FDA
establishment number for the manufacturing site and inclusion of the particular
product on the manufacturer's drug listing with the FDA; or
c. For an active pharmaceutical ingredient,
evidence that the manufacturer's bulk drug substance is identified as an
ingredient in an FDA approved finished product; or
d. Other direct evidence of FDA authorization
for the importation and commercial distribution of the product.
Updates to the list of prescription drugs being imported and
documentation of FDA approval must be submitted to the department prior to
importation of any prescription drug under the non-resident Rx drug
manufacturer's permit. It is the non-resident manufacturer's responsibility to
assure that it is only importing approved prescription drugs into Florida and
is complying with section
499.023, F.S. Compliance with
submission of the information required in this rule does not mean that the
prescription drug does in fact comply with all provisions of the Federal Act
and chapter 499, F.S., and may be imported.
7. Pay the appropriate fee(s) as required by
rule
61N-1.018, F.A.C.
8. Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule
chapter.
(7)
Wholesaler Permits.
(a) A person applying for
or renewing a permit as a prescription drug wholesaler, or as a veterinary
prescription drug wholesaler located in Florida, must have an area for the
storage of prescription drugs under controlled room temperature and
refrigeration, as required by paragraph
61N-1.013(3)(d),
F.A.C., whether or not the person intends to wholesale prescription drugs
requiring storage under controlled room temperature conditions or
refrigeration; except that a person who will act as a broker only of
prescription drugs may apply for a "broker only" designation on the
Prescription Drug Wholesaler permit and then the requirement that the permitted
address provide for "controlled room temperature" and refrigeration is waived.
A "broker only" cannot take possession of prescription drugs under any
circumstances.
(b) The Prescription
Drug Wholesaler's bond and the bond for an out-of-state prescription drug
wholesaler will be transferred by the department to subsequent permits issued
pursuant to renewal applications if the bond or other equivalent means of
security is in a form that will allow for such transfer. The bond will be
refunded without interest, consistent with the provisions of section
499.012(2),
F.S. In order for another means of security to satisfy the bond requirement,
the security must be in a form that the applicant or permittee cannot revoke,
withdraw, cancel, or otherwise reduce the department's interest until the
conditions upon which the bond can be refunded or released, as set forth in
section 499.012(2),
F.S., have been satisfied. If the bond or other security is in a form that
requires the department to initiate release of the bond or security, a
prescription drug wholesaler or out-of-state prescription drug wholesaler
should request in writing that the department release the bond or security
within 45 days of satisfaction of the conditions in sections
499.012(2)(a) and
(c), F.S., that release department's interest
in the bond or other security. The department must initiate release of the bond
or security within 10 working days of satisfaction of the conditions in
sections 499.012(2)(a) and
(c), F.S., unless the department has
otherwise made a claim against the bond or security.
(c) A Prescription Drug Wholesaler is
authorized to wholesale all prescription drugs, including compressed medical
gases and therefore does not require dual permits.
(d) Application requirements for Compressed
Medical Gases Wholesalers include:
1. Contact
the department's Drugs, Devices, and Cosmetics Program to request an
application or download the application from the department's
website.
2. File with the
department a completed application for a permit using an original Form DH 1033,
"Application for Permit Under chapter 499, F.S., " effective August
2004.
3. Pay the appropriate fee(s)
as required by rule
61N-1.018, F.A.C.
4. Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule
chapter.
(e) Application
requirements for Prescription Drug Wholesalers, Prescription Drug Wholesalers -
Broker Only, or Out-of-State Prescription Drug Wholesalers include:
1. Contact the department's Drugs, Devices,
and Cosmetics Program for an application form(s) and fingerprint cards. Both
the sales transaction (seller) and the physical movement (location from which
the drugs are shipped) of prescription drugs are considered wholesale
distribution. Therefore, if the seller (name and address as reflected on the
invoice) is not the same as the location from which the drugs are shipped (name
and address), such as in the case of brokers, different branches of the same
company, or a contract warehouse, then both persons (the seller and location
from which shipped) must be permitted under the Florida Drug and Cosmetic
Act.
2. File with the department a
completed application for a permit using an original Form DH 2124,
"Prescription Drug Wholesaler/Out-of-State Prescription Drug Wholesaler
Application" effective January 2004, which is incorporated by reference
herein.
3. File with the department
an original Form DH 2125, "Personal Information Statement" effective January
2004, which is incorporated by reference herein for the applicant's manager,
next four highest ranking employees that are responsible for prescription drug
operations, and all affiliated parties.
4. Submit a legible fingerprint card and
$47.00 per fingerprint card for each person required to submit a fingerprint
card. These fingerprint cards must have been obtained from the department so
that the cards will have the proper coding for processing and
reporting.
5. Submit a $100, 000
bond or security as specified in sections
499.012(2)(a) and
(c), F.S., and paragraph (b), above. If you
are using a surety bond, the required bond form is DH 2128, "Surety Bond Form,
" effective June 2005, which is incorporated by reference herein.
6. If the applicant is located outside of
Florida, submit a photocopy of the resident state's license or permit that
authorizes the wholesale distribution of prescription drugs. If the resident
state does not allow photocopying of the license or permit, the applicant may
submit a verification of the license or permit from the issuing agency. If the
resident state does not require a license or permit for the wholesale
distribution activities of the applicant in that state, submit:
a. A written confirmation on the letterhead
of the resident state agency responsible for regulating prescription drug
wholesale distribution in that state that permitting of the applicant
establishment is not required by that state; and
b. A statement signed by the applicant that
the applicant will comply with all storage, handling, and recordkeeping
requirements of the resident state related to the sale and physical
distribution of prescription drugs into Florida, or if none exist in the
resident state that the applicant will comply with all storage, handling, and
recordkeeping requirements, as set forth in
21 C.F.R.
205.50 (as of 10/1/03) which is incorporated
by reference herein, for the sale and physical distribution of prescription
drugs into Florida.
7.
Identify a person who has been Certified pursuant to section
499.012(11),
F.S., to serve as the certified designated representative. If the prescription
drug wholesaler operates in 'shift' schedules, a different person per shift may
be designated; however the shift hours for which each person is responsible
must be clearly identified. You must use Notification of Designated
Representative Form DH 2130, effective June 2005, which is incorporated by
reference herein, for communicating changes in the designated
representative.
8. Pay the
appropriate fee(s) as required by rule
61N-1.018, F.A.C.
9. Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule
chapter.
(f) Application
requirements for Retail Pharmacy Wholesalers include:
1. Contact the department's Drugs, Devices,
and Cosmetics Program to request an application or download the application
from the department's website.
2.
File with the department a completed application for a permit using an original
Form DH 1033, "Application for Permit Under chapter 499, F.S., " effective
August 2004.
3. Submit a photocopy
of all permits issued to the applicant's address which authorize the purchase
of prescription drugs at that address, regardless of the issuing
agency.
4. Pay the appropriate
fee(s) as required by rule
61N-1.018, F.A.C.
5. Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule
chapter.
(g) Application
requirements for freight forwarders.
1.
Contact the department's Drugs, Devices, and Cosmetics Program to request an
application or download the application from the department's
website.
2. File with the
department a completed application for a permit using an original Form DH 1033,
"Application for Permit Under chapter 499, F.S., " effective August
2004.
3. Pay the appropriate fee(s)
as required by rule
61N-1.018, F.A.C.
4. Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule
chapter.
(h) Application
requirements for Veterinary Prescription Drug Wholesalers include:
1. Contact the department's Drugs, Devices,
and Cosmetics Program to request an application or download the application
from the department's website.
2.
File with the department a completed application for a permit using an original
Form DH 1033, "Application for Permit Under chapter 499, F.S., " effective
August 2004, and the attachment for the Veterinary Prescription Drug Wholesaler
permit, August 2004.
3. Pay the
appropriate fee(s) as required by rule
61N-1.018, F.A.C.
4. Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule
chapter.
(8)
Other Distributors. Persons conducting certain distributions of prescription
drugs which are not considered wholesale distributions in the state of Florida
must obtain a permit from the department prior to initiating that activity.
These permits include Complimentary Drug Distributors, all of the designated
Restricted Rx Drug Distributor permits as further discussed in rule
61N-1.023, F.A.C., Medical
Oxygen Retailers, and Veterinary Legend Drug Retailers.
(a) Application requirements for
Complimentary Drug Distributors include:
1.
Contact the department's Drugs, Devices, and Cosmetics Program for an
application form or download the application from the department's website. An
out of the state manufacturer or distributor of complimentary or sample
prescription drugs may obtain a "Complimentary Drug Distributor permit" for its
headquarters or home office in lieu of a permit for each establishment from
which complimentary prescription drugs are distributed. A manufacturer or
distributor that uses a fulfillment house, shipping and mailing service, or
distributes through co-marketing agreements, must notify the department in
writing of the contractor's name, address, and responsibilities prior to the
distribution of prescription drug samples in or into this state. The
headquarters or home office location is responsible for all recordkeeping
requirements and for production of such records as required by sections
499.0121 and
499.028, F.S., this rule and
rule
61N-1.012, F.A.C. A person
located within the state that manufactures or distributes complimentary or
sample prescription drugs directly or through its agents, employees, or
independent contractors, must obtain a Complimentary Drug Distributor permit
for each establishment located in Florida. A manufacturer or distributor that
uses a fulfillment house, shipping and mailing service, or distributes through
co-marketing agreements, any of which is located in Florida, must obtain a
permit in the name of the manufacturer or distributor issued to the address of
the fulfillment house, shipping and mailing service, or similar location. The
manufacturer or distributor is responsible for all recordkeeping requirements
and for production of such records as required by sections
499.0121 and
499.028, F.S., this rule and
rule
61N-1.012, F.A.C.
2. File with the department a completed
application for a permit using an original Form DH 1033, "Application for
Permit Under chapter 499, F.S., " effective August 2004.
3. Submit a copy of the applicant's license
or permit which authorizes the possession of prescription drugs. If the issuing
agency does not allow photocopying of a license or permit, the applicant may
submit a verification of the license or permit from the issuing
agency.
4. Pay the appropriate
fee(s) as required by rule
61N-1.018, F.A.C.
5. Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule
chapter.
(b) Application
requirements for Restricted Rx Drug Distributor - Health Care Entity include:
1. Contact the department's Drugs, Devices,
and Cosmetics Program to request an application or download the application
from the department's website.
2.
File with the department a completed application for a permit using an original
Form DH 1033, "Application for Permit Under chapter 499, F.S., " effective
August 2004.
3. Submit a listing of
all the locations under common control that will be receiving distributions
under this permit. This listing must include the name and address of the
facility and the pharmacy or other permit number which authorizes that location
to possess prescription drugs. Additional locations must be communicated to the
department in writing prior to the transfer of prescription drugs.
Alternatively, depending on the basis for the application, provide a copy of
the written contract evidencing the group purchasing organization and a listing
of all the locations that will be receiving distributions under this permit
because of joint membership in the group purchasing organization.
4. Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule chapter.
5. Pay the appropriate fee(s) as required by
rule
61N-1.018,
F.A.C.
(c) Application
requirements for Restricted Rx Drug Distributor - Charitable Organization
include:
1. Contact the department's Drugs,
Devices, and Cosmetics Program to request an application or download the
application from the department's website.
2. File with the department a completed
application for a permit using an original Form DH 1033, "Application for
Permit Under chapter 499, F.S., " effective August 2004.
3. Submit proof of the charitable
organization designation under section
501(c)(3) of
the Internal Revenue Code.
4. If
the FDA has initiated the enrollment program, submit the FDA central file
number of the applicant.
5. Comply
with all the requirements for permitting provided in chapter 499, F.S., and
this rule chapter.
6. Pay the
appropriate fee(s) as required by rule
61N-1.018,
F.A.C.
(d) Application
requirements for Restricted Rx Drug Distributor - Reverse Distributor or
Restricted Rx Drug Distributor - Destruction include:
1. Contact the department's Drugs, Devices,
and Cosmetics Program to request an application or download the application
from the department's website.
2.
File with the department a completed application for a permit using an original
Form DH 1033, "Application for Permit Under chapter 499, F.S., " effective
August 2004.
3. Comply with all the
requirements for permitting provided in chapter 499, F.S., and this rule
chapter.
4. Pay the appropriate
fee(s) as required by rule
61N-1.018,
F.A.C.
(e) Application
requirements for Restricted Rx Drug Distributor - Government Programs include:
1. Contact the department's Drugs, Devices,
and Cosmetics Program to request an application or download the application
from the department's website.
2.
File with the department a completed application for a permit using an original
Form DH 1033, "Application for Permit Under chapter 499, F.S., " effective
August 2004.
3. Submit a detailed
plan justifying the necessity for this permit in accordance with subsection
61N-1.023(5),
F.A.C.
4. Submit a list of the
intended contractors and subcontractors that will receive the entity's
prescription drugs under this permit and the permit numbers that authorize them
to administer or dispense. Also submit a copy of the provisions of the contract
that address the requirements in section 499.012(1)(a)1.d., F.S.
5. Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule chapter.
6. Pay the appropriate fee(s) as required by
rule
61N-1.018,
F.A.C.
(f) Application
requirements for a Restricted Rx Drug Distributor - Institutional Research
include:
1. Contact the department's Drugs,
Devices, and Cosmetics Program to request an application or download the
application from the department's website.
2. File with the department a completed
application for a permit using an original Form DH 1033, "Application for
Permit Under chapter 499, F.S., " effective August 2004.
3. Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule chapter.
4. Pay the appropriate fee(s) as required by
rule
61N-1.018,
F.A.C.
(g) Application
requirements for a Veterinary Legend Drug Retailer include:
1. Contact the department's Drugs, Devices,
and Cosmetics Program to request an application or download the application
from the department's website.
2.
File with the department a completed application for a permit using an original
Form DH 1033, "Application for Permit Under chapter 499, F.S., " effective
August 2004.
3. Pay the appropriate
fee(s) as required by Rule
61N-1.018, F.A.C.
4. Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule
chapter.
(h) Application
requirements for a Medical Oxygen Retailer include:
1. Contact the department's Drugs, Devices,
and Cosmetics Program to request an application or download the application
from the department's website.
2.
File with the department a completed application for a permit using an original
Form DH 1033, "Application for Permit Under chapter 499, F.S., " effective
August 2004.
3. Pay the appropriate
fee(s) as required by rule
61N-1.018, F.A.C.
4. Comply with all the requirements for
permitting provided in chapter 499, F.S., and these rules.
5. Have an FDA establishment registration
number if the establishment will be transfilling medical
oxygen.
(9)
Designated Representative.
(a) For purposes of
the work experience required to be certified as a designated representative:
1. Serving in a managerial capacity does not
require actual supervisory responsibilities over employees, but requires a
level of responsibility consistent with a managerial employee, including but
not limited to decision-making authority, responsibility for developing and
implementing policies and procedures related to purchasing, sales, or inventory
management for prescription drugs.
2. Responsibilities related to recordkeeping
for prescription drugs by a person who worked in a pharmacy may include such
activities as, practicing pharmacy pursuant to a valid pharmacy license,
routinely purchasing or ordering prescription drugs where cognitive functions
were involved and the order is not the result of an automated reorder system,
routinely receiving prescription drugs and verifying the accuracy of the order,
routinely taking a physical inventory of prescription drugs, routinely
assessing the pharmacy shelves for outdated prescription drugs, and routinely
completing an inventory for the transfer of adulterated prescription drugs for
appropriate disposal.
(b)
Application requirements for Certification as a Designated Representative
include:
1. Contact the department's Drugs,
Devices, and Cosmetics Program to request an application and fingerprint cards
or download the application from the program's web site.
2. File with the department a completed
application for certification using Form DH 2126 "Application for Certification
as a Designated Representative, " effective June 2005, which is incorporated by
reference herein. An application is not deemed completed until the applicant
has received a passing score on the laws and rules examination required by
section 499.012(16)(b)4., F.S. The applicant will be notified by regular mail
at the applicant's home mailing address of the applicant's eligibility to
schedule the laws and rules examination. Information on scheduling and other
testing processes are included on the program's website in a document entitled
"Candidate's Information Booklet." If the applicant has not
passed the laws and rules examination within six months of this notification,
the department will initiate action to deny the Application for Certification
as a Designated Representative. This six-month period for an applicant to pass
the laws and rules examination does not extend the statutory requirement in
section 499.012(16)(f),
F.S., for a Prescription Drug Wholesaler Distributor or an out-of-state
Prescription Drug Wholesaler Distributor to employ a designated
representative.
3. Submit a legible
fingerprint card and $47.00 per fingerprint card. The fingerprint card must
have been obtained from the department so that the card will have the proper
coding for processing and reporting.
4. Pay the appropriate fee(s) as required by
rule
61N-1.018, F.A.C.
5. Comply with all requirements for
certification provided in chapter 499, F.S., and these
rules.
(10)
Permit renewals for all permits other than a prescription drug wholesaler,
prescription drug wholesaler - broker only, or out-of-state prescription drug
wholesaler. Submission of a renewal application represents to the department
that conditions have not changed with the permitted person which would make the
permitted person ineligible to renew the permit.
(a) A permit renewed during the grace period
will expire 24 months after the last day of the anniversary month in which the
previous permit expired.
(b) An
applicant applying to renew a permit which has not expired, been revoked,
suspended or otherwise terminated must:
1.
File with the department a completed application for a permit using an
"Application for Permit Renewal Under chapter 499, F.S., " Form DH 1034,
effective January 2004, which is incorporated by reference herein. The
permittee should contact the department if the renewal application has not been
received at least 30 days prior to the permit's expiration date.
2. Pay the appropriate fee pursuant to this
section and rule
61N-1.018, F.A.C.
3. Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule chapter.
4. Applicants renewing a Retail Pharmacy
Wholesaler's permit must also submit a legible photocopy of the current
community pharmacy permit.
(c) If a permit is not renewed prior to the
expiration date or within the grace period, the person will be placed
out-of-business for purposes of chapter 499, F.S. In order to be permitted
after the expiration of the 60-day grace period, a person must submit a new
application and proceed according to the requirements for submission of a new
application.
(11) Permit
renewals for prescription drug wholesaler, prescription drug wholesaler -
broker only, or out-of-state prescription drug wholesaler.
(a) The program will mail an application for
renewal of the prescription drug wholesaler, prescription drug wholesaler -
broker only, or out-of-state prescription drug wholesaler permit at least 90
days prior to the expiration date of the permit.
(b) A renewal application that is postmarked
within 45 days prior to the expiration date of the permit must include
submission of a $100 delinquent fee in addition to the annual permit fee,
fingerprint fees, and bond.
(c)
File with the department a completed application for a permit using an original
Form DH 2124, "Prescription Drug Wholesaler/Out-of-State Prescription Drug
Wholesaler Application" effective January 2004.
(d) File with the department an original Form
DH 2125, "Personal Information Statement" effective January 2004, for the
applicant's manager, next four highest ranking employees that are responsible
for prescription drug operations, and all affiliated parties.
(e) Submit a legible fingerprint card for any
person for whom a Personal Information Statement is submitted who has not
previously submitted a fingerprint card on behalf of the applicant company.
These fingerprint cards must have been obtained from the department so that the
cards will have the proper coding for processing and reporting.
(f) Submit $47.00 for each fingerprint card
submitted.
(g) Submit a $100, 000
bond or security as specified in sections
499.012(2)(a) and
(c), F.S., and paragraph (7)(b), above. If
you are using a surety bond, the required bond form is DH 2128, "Surety Bond
Form, " effective June 2005.
(h) If
the applicant is located outside of Florida, submit a photocopy of the resident
state's current license or permit that authorizes the wholesale distribution of
prescription drugs. If the resident state does not allow photocopying of the
license or permit, the applicant may submit a verification of the license or
permit from the issuing agency. If the resident state does not require a
license or permit for the wholesale distribution activities of the applicant in
that state, submit:
1. A written confirmation
on the letterhead of the resident state agency responsible for regulating
prescription drug wholesale distribution in that state that permitting of the
applicant establishment is not required by that state; and
2. A statement signed by the applicant that
the applicant will comply with all storage, handling, and recordkeeping
requirements of the resident state related to the sale and physical
distribution of prescription drugs into Florida, or if none exist in the
resident state that the applicant will comply with all storage, handling, and
recordkeeping requirements, as set forth in
21 C.F.R.
205.50 (as of 10/1/03) which is incorporated
by reference herein, for the sale and physical distribution of prescription
drugs into Florida.
(i)
Pay the appropriate fee(s) as required by rule
61N-1.018, F.A.C.
(j) Comply with all the requirements for
permitting provided in chapter 499, F.S., and this rule
chapter.